logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Michael J. Pishvaian

Johns Hopkins University
H指数:49
被引数:9,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

携带KRAS突变肽疫苗及双重检查点封锁的转移性结直肠癌：一项I期临床试验

Nature Communications
IF15.7
2026-06-230
OAAI
Hejia Henry Wang; Amanda L. Huff; S. Daniel Haldar; Maureen Berg; Christopher Thoburn; Thatcher R. Heumann; Robert A. Anders; Benjamin Barrett; Katherine M. Bever; Michael J. Pishvaian; Valerie Lee; Dung T. Le; Eric S. Christenson; Marina Baretti; Mark Yarchoan; Daniel Laheru; Amy Thomas; Jennifer N. Durham; Julie M. Nauroth; Jiayun Lu; Hao Wang; Elizabeth M. Jaffee; Nilofer S. Azad; Neeha Zaidi
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study

联合使用癌症疫苗、pembrolizumab 和立体定向体部放射治疗局部晚期胰腺癌患者的疗效：一项单臂、II 期研究

Nature Communications
IF15.7
2026-03-180
OAAI
Valerie Lee; Apoorvaa S. Sachidanand; Christina Rodriguez; Junke Wang; Beth Onners; Hanfei Qi; Rose Parkinson; Thomas McPhaul; Jennifer Durham; Ding Ding; Amy Hacker-Prietz; Amol K. Narang; Dung T. Le; Ana De Jesus; Michael Pishvaian; Eric Christenson; Elizabeth D. Thompson; Robert A. Anders; Arsen Osipov; Matthew Weiss; William Burns; Richard Burkhart; Kelly Lafaro; Jin He; Christopher L. Wolfgang; Elizabeth Sugar; Joseph M. Herman; Elizabeth M. Jaffee; Hao Wang; Daniel A. Laheru; Lei Zheng
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

肺内转移型和肝内转移型胰腺癌的临床结局与分子特征：真实世界证据数据库的结果

ONCOLOGIST
IF4.2
2025-03-130
OA
Levi, Abrahm; Blais, Edik; Davelaar, John; Ebia, Matthew, I; Minasyan, Angela; Nikravesh, Nima; Gresham, Gillian; Zheng, Lei; Chuy, Jennifer W.; Shroff, Rachna T.; Wadlow, Raymond Couric; Dearbeloa, Patricia; Matrisian, Lynn McCormick; Petricoin, Emmanuel; Pishvaian, Michael J.; Gong, Jun; Hendifar, Andrew Eugene; Osipov, Arsen
Temporal stability and chemotherapy responsiveness of classical and basal transcriptional subtypes of pancreatic cancer
CANCER RESEARCH
IF16.6
2024-09-150
PRE
Singh, Harshabad; Xiu, Joanne; Kapner, Kevin; Yuan, Chen; Narayan, Raja R.; Oberley, Matthew; Farrell, Alex; Surana, Rishi; Huffmann, Brandon M.; Perez, Kimberly J.; Cleary, James M.; Jordan, Alexander C.; Costa, Andressa Dias; Williams, Hannah L.; Raghavan, Srivatsan; Weinberg, Benjamin; Pishvaian, Michael J.; Shroff, Rachna T.; Goel, Sanjay; Dougan, Stephanie K.; Nowak, Jonathan; Spetzler, David; Sledge, George; Wolpin, Brian M.; Aguirre, Andrew J.
An analysis of outcomes in patients (pts) with advanced pancreatic cancer (PDAC) whose tumors harbor pathogenic BRCA1 or BRCA2 mutations based on gene mutation location
CANCER RESEARCH
IF16.6
2024-09-150
PRE
Hur, Jamie; McPhaul, Thomas; Cunningham, Dea; Zheng, Lei; Pishvaian, Christopher J.; Laheru, Daniel; De Jesus-Acosta, Ana; Le, Dung; Zaidi, Neeha; Azad, Nilo; Browner, Ilene; Burns, William R.; Burkhart, Richard; Lafaro, Kelly; Narang, Amol; He, Jin; Lee, Valerie; Brody, Jonathan R.; Pishvaian, Michael J.
The Phase III Study: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC)
ANNALS OF ONCOLOGY
IF65.4
2023-06-011
OA
Pishvaian, M.; Lopez, C.; Zervos, E.; Hatoum, H.; Berg, D.; Ucar, A.; Boone, B.; Johnson, T.; Zureikat, A.; Kenneth, M.; Chung, K.; Gandhi, R.; Nazemzadeh, R.; Parikh, N.; Novelli, P.; Kouri, B.; Laing, C.; Bates, S.; Agah, R.; Goodman, K.
Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following Induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC) - phase III trial interim analysis
CANCER RESEARCH
IF16.6
2023-04-141
PRE
Pishvaian, Michael; Zureikat, Amer; Lopez, Charles; Meredith, Kenneth; Zervos, Emmanuel; Hatoum, Hassan; Chung, Ki; Berg, Daniel J.; Ucar, Antonio; Gandhi, Ripal; Nazemzadeh, Reza; Nainesh, Parikh; Novelli, Paula; Kouri, Brian; Laing, Christopher; Boone, Brian; Johnson, Thor; Bates, Susan; Goodman, Karyn; Agah, Ramtin
Safety and efficacy of three PARP inhibitors (PARPi) combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor (ATRi) camonsertib in patients (pts) with solid tumors harboring DNA damage response (DDR) alterations
CANCER RESEARCH
IF16.6
2023-04-140
PRE
Yap, Timothy A.; Yadav, Siddhartha; Herzberg, Benjamin; Carneiro, Benedito A.; Fontana, Elisa; Hojgaard, Martin; Pishvaian, Michael J.; Plummer, Ruth; Werner, Theresa L.; Sahai, Vaibhav; Lheureux, Stephanie; Lee, Elizabeth K.; Mettu, Niharika B.; Cote, Gregory M.; Schonhoft, Joseph D.; Rimkunas, Victoria; Silverman, Ian M.; Wainszelbaum, Marisa; Peltz, Gerson; Fretland, Adrian J.; Fei, Kezhen; Ulanet, Danielle; Kim, Insil; Koehler, Maria; Rosen, Ezra; Cecchini, Michael
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
MOLECULAR CANCER THERAPEUTICS
IF5.5
2021-08-1921
OA
Schultz, Christopher W.; McCarthy, Grace A.; Nerwal, Teena; Nevler, Avinoam; DuHadaway, James B.; McCoy, Matthew D.; Jiang, Wei; Brown, Samantha Z.; Goetz, Austin; Jain, Aditi; Calvert, Valerie S.; Vishwakarma, Vikalp; Wang, Dezhen; Preet, Ranjan; Cassel, Joel; Summer, Ross; Shaghaghi, Hoora; Pommier, Yves; Baechler, Simone A.; Pishvaian, Michael J.; Golan, Talia; Yeo, Charles J.; Petricoin, Emanuel F.; Prendergast, George C.; Salvino, Joseph; Singh, Pankaj K.; Dixon, Dan A.; Brody, Jonathan R.

研究方向

暂未获取到该数据
J
Jonathan R. Brody
H 指数:59论文数:683被引数:1.1万
J
John L. Marshall
H 指数:83论文数:833被引数:2.6万
C
Charles J. Yeo
H 指数:132论文数:959被引数:8.1万
S
Subha Madhavan
H 指数:40论文数:304被引数:8,769
J
Jordan M. Winter
H 指数:57论文数:571被引数:1.7万
A
Aiwu Ruth He
H 指数:42论文数:366被引数:1.1万
L
Lynn M. Matrisian
H 指数:99论文数:409被引数:4.8万
A
Aditi Jain
H 指数:30论文数:268被引数:2,865
D
Daniel A. Laheru
H 指数:77论文数:636被引数:3.6万
D
Dung T. Le
H 指数:66论文数:513被引数:4.9万